Cargando…

Utility of Circulating Tumor DNA in Different Clinical Scenarios of Breast Cancer

SIMPLE SUMMARY: This review is focused on the concept of a specific type of “liquid biopsy”, circulating cell-free tumor DNA (ctDNA). It explores the advantages and limitations of using this technique and the latest advances of using it in different clinical scenarios of breast cancer: early, metast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mesquita, Alexandra, Costa, José Luís, Schmitt, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766337/ https://www.ncbi.nlm.nih.gov/pubmed/33339259 http://dx.doi.org/10.3390/cancers12123797

Ejemplares similares

Clinical utility of circulating tumor DNA for colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2019)

Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers
por: Okuma, Hitomi Sumiyoshi, et al.
Publicado: (2021)

The Clinical Utility of Droplet Digital PCR for Profiling Circulating Tumor DNA in Breast Cancer Patients
por: Gezer, Ugur, et al.
Publicado: (2022)

Circulating tumor DNA: current challenges for clinical utility
por: Dang, Donna K., et al.
Publicado: (2022)

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer
por: Takai, Erina, et al.
Publicado: (2015)

Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker
por: Wang, Ru, et al.
Publicado: (2017)

Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility
por: Brenner Thomsen, Caroline, et al.
Publicado: (2022)

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023)

Clinical Evidence of Circulating Tumor DNA Application in Aggressive Breast Cancer
por: El Hejjioui, Brahim, et al.
Publicado: (2023)

Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer
por: Zhou, Yidong, et al.
Publicado: (2019)

Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates
por: Chedid, Julien, et al.
Publicado: (2022)

Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers
por: Addanki, Sridevi, et al.
Publicado: (2022)

Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
por: Fiala, Clare, et al.
Publicado: (2018)

Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
por: Boonstra, Pieter A., et al.
Publicado: (2020)

Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios
por: Khaddour, Karam, et al.
Publicado: (2022)

Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios
por: Agarwal, Ashok, et al.
Publicado: (2016)

Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios
por: Raheem, Omer A., et al.
Publicado: (2017)

Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios
por: Basar, Murad M., et al.
Publicado: (2017)

Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression
por: Moss, Esther L., et al.
Publicado: (2020)

Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells
por: Yeo, Dannel, et al.
Publicado: (2022)

Clinical Utility of Circulating Tumor Cells in Patients With Esophageal Cancer
por: Li, Yang, et al.
Publicado: (2022)

Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
por: Yi, Zongbi, et al.
Publicado: (2017)

Advances in the Detection Technologies and Clinical Applications of Circulating Tumor DNA in Metastatic Breast Cancer
por: Liao, Hao, et al.
Publicado: (2020)

Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma
por: Cabalag, Carlos S., et al.
Publicado: (2022)

Clinical utility of circulating cell-free DNA in advanced colorectal cancer
por: Pereira, Allan A. Lima, et al.
Publicado: (2017)

The dynamic range of circulating tumor DNA in metastatic breast cancer
por: Heidary, Maryam, et al.
Publicado: (2014)

The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer
por: Shoukry, Mira, et al.
Publicado: (2021)

Circulating Tumor DNA in the Management of Early-Stage Breast Cancer
por: Vlataki, Katerina, et al.
Publicado: (2023)

Clinical utility of circulating tumor cells: an update
por: Vasseur, Antoine, et al.
Publicado: (2020)

Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies
por: Tellez-Gabriel, Marta, et al.
Publicado: (2020)

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2021)

Clinical utility and applicability of circulating tumor DNA testing in esophageal cancer: a systematic review and meta-analysis
por: Chidambaram, Swathikan, et al.
Publicado: (2021)

Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients
por: Park, Gahee, et al.
Publicado: (2018)

Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
por: Cha, Yongjun, et al.
Publicado: (2023)

Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility
por: Petrik, József, et al.
Publicado: (2022)

Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer
por: Prat, Aleix, et al.
Publicado: (2023)

Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors
por: Zhou, Cathy, et al.
Publicado: (2018)

The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy
por: Kosovec, Juliann E., et al.
Publicado: (2018)

Utility of sperm DNA fragmentation testing in different clinical scenarios of male reproductive abnormalities and its influence in natural and assisted reproduction
por: Hallak, Jorge
Publicado: (2017)

The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients
por: Elshimali, Yahya I., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_03733jvsehgi7scpnkbplv39qr